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Chromatin remodeling complexThe neuregulin-1 (Nrg-1) gene is translated into several protein isoforms, which are either secreted or
membrane-anchored. In vitro, neural stem cells (NSC) express mainly the cystein-rich-domain NRG (CRD-
NRG) isoform, a membrane-anchored type III form. This isoform exhibits a cystein-rich-domain, which
constitutes a second transmembrane domain and can be cleaved to release both a signaling EGF-containing
domain (ECD) at the cell surface and an intracellular domain (ICD). The main goal of this paper was to
determine the exact role of ECD and ICD in NSC survival and differentiation. Using an siRNA approach, we
demonstrated that CRD-NRG inhibition was followed by a decrease in NSC proliferation and of neuronal or
oligodendroglial differentiation. Overexpression of ICD but not ECD was followed by a decrease in NSC
proliferation and an increase in neuronal and oligodendroglial differentiation. Moreover, we showed that ICD
physically interacted in cultured NSC with BRM and BAF57, two members of the Swi/Snf remodeling
complex, and that ICD stimulation of neuronal cell differentiation is dependent on the presence of BAF57.
© 2009 Elsevier Inc. All rights reserved.Introduction
Among growth factors that could modulate nervous system
development, neuregulins (NRG) constitute a specialized family of
growth factors, which are better known as regulators of various
aspects of the nervous system biology (Adlkofer and Lai, 2000;
Leimeroth et al., 2002; Lai and Feng, 2004). Each isoform of neuregulin
contains an extracellular EGF-like motif, the hallmark of the
neuregulin family, which consists of four genes: Nrg-1 (Britsch,
2007), Nrg-2 (Carraway et al., 1997; Chang et al., 1997), Nrg-3 (Hijazi
et al., 1998; Zhang et al., 1997) and Nrg-4 (Harari et al., 1999). The
diversity of the Nrg-1-encoded protein results from an alternative
splicing of a primary transcript (Steinthorsdottir et al., 2004). The
Nrg-1 protein isoforms have been classiﬁed into three groups
according to the structure of their N-terminal region: type I, or
acetylcholine receptor-inducting activity (ARIA) (Corfas et al., 1993),
and neu-differentiation factor (NDF) (Wen et al., 1992; Falls et al.,
1993); type II, or glial growth factor 2 (GGF2) (Marchionni et al.,
1993; Bermingham-McDonogh et al., 1997) and type III, or cystein-
rich-domain (CRD-NRG) (Buonanno and Fischbach, 2001). More
recently, it was reported that three lesser-known isoforms are alsorch Center, University of Liège,
elgium. Fax: +32 4 366 59 12.
ter).
l rights reserved.
euregulin-1 modulates the d
2009), doi:10.1016/j.mcn.20expressed; type IV, V and VI, leading to 31 isoforms being detected by
analysis of human expressed sequence tags (Tan et al., 2007).
All these isoforms are known to exhibit various activities during
nervous system development (Esper et al., 2006). Indeed, Nrg-1-
encoded proteins promote proliferation, differentiation and myelina-
tion of Schwann cells (Leimeroth et al., 2002) and oligodendrocytes
(Raabe et al., 1996). They also promote maturation and survival of
astrocytes (Pinkas-Kramarski et al., 1994). In neurons, Nrg-1-encoded
neuregulins induce neuronal migration, and selectively increase the
expression of several neurotransmitter receptors (Loeb, 2003). They
are also implicated in synaptic plasticity (Mei and Xiong, 2008).
The Nrg-1-encoded third group protein, CRD-NRG, is expressed by
neural stem cells (NSC) in culture (Calaora et al., 2001). CRD-NRG is
characterized by two transmembrane regions, and a cleavage
releasing the extracellular domain (ECD), which is able to recruit
ErbB receptors, and the intracellular domain (ICD) (Frenzel and Falls,
2001). However, ICD has also been detected in neuronal nuclei,
suggesting a role in neuronal survival as a consequence of a retrograde
signaling mechanism (Bao et al., 2003).
We previously demonstrated that the inhibition of NRG using a
recombinant and soluble form of ErbB receptor is followed by a
decrease in NSC proliferation and survival and by a premature
oligodendroglial differentiation in surviving NSC (Calaora et al., 2001).
In this paper, we analyzed the distribution of Nrg-1-encoded isoforms
in cultured mouse NSC, as well as, in cultured neurons, astrocytes and
oligodendrocytes in order to unravel a possible speciﬁc distribution ofifferentiation of neural stem cells in vitro trough an interaction with
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ARTICLE IN PRESSICD and ECD in immature or differentiated cell types. We then
investigated the effects of ECD and ICD on proliferation and
differentiation of NSC by modulating their expression. Finally, we
demonstrated that ICD can interact with BAF57 (or Smarce1) and Brm
or (Smarca2), two members of the Swi/Snf remodeling complex.
Results
Subcellular distribution of the extra- and the intracellular domain in
proliferating and differentiating neural stem cells in culture
In order to determine the subcellular distribution of the extracel-
lular domain (ECD) and the intracellular domain (ICD) of Nrg-1-
encoded isoforms, we performed compartmental protein extractions
on proliferating and differentiating cultured neural stem cells (NSC),
allowing us to extract speciﬁcally either cytoplasmic or membranous
or nuclei proteins (see Fig. S3). Bearing in mind the fact that CRD-NRG
is the prevalent Nrg-1-encoded isoform expressed by proliferating
NSC in culture (Calaora et al., 2001) and most available antibodiesFig. 1. Distribution at the subcellular level of the extracellular and intracellular domain of Nrg
the full length protein (140 kDa) anchored in the membrane and the secreted form (29 kDa
(A) and neurons (B). In astrocytes, we observed a full length form in themembrane protein ex
1 type I membrane-anchored isoform. We also identiﬁed a 42 kDa signal in cytoplasmic frac
the 140 kDa and 29 kDawere also present as a 120 kDa signal in the cytoplasmic fraction (D).
55 kDa signal in the membrane and nuclear protein extract fractions from the four types o
Please cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
the Swi/Snf complex, Mol. Cell. Neurosci. (2009), doi:10.1016/j.mcn.20recognize either α or β Nrg-1-encoded isoforms, we designed a
monoclonal antibody against CRD-NRG with an epitope located in the
ECD region (a complete description of the D11monoclonal antibody is
available in Fig. S1 and S2).
D11 monoclonal antibody was tested in western blot experiments
using compartmental protein extracts. In NSC, a 29 kDa signal was
observed in cytoplasmic protein extracts (Fig. 1A), corresponding to
the secreted isoform devolved to be released at the cell surface (Loeb
et al., 1998). In themembrane protein fraction, we observed a 140 kDa
signal corresponding to the full length protein anchored in the
membrane (Fig. 1A). An identical proﬁle of the ECD distribution was
observed in compartmental extracts prepared using cultured neurons
(Fig. 1B). In compartmental protein extracts prepared from cultured
astrocytes, the distribution was different, as we observed, in addition
to the 29 kDa signal, a 42 kDa signal in the cytoplasmic fraction that
could correspond to the NDF isoform (Fig. 1C). Furthermore, the
molecular weight of the signal present in the membrane protein
fraction was 110 kDa instead of 140 kDa (Fig. 1C), suggesting that D11
monoclonal antibody seemed thus also to recognize type I isoforms. In-1. Western blots using D11monoclonal antibody allowed us to observe the presence of
) of the extracellular domain in the cytoplasmic protein extracts from neural stem cells
tracts, which exhibited a 110 kDamolecular weight probably corresponding to the Nrg-
tion (NDF isoform), which is the secreted form of Nrg-1 type I (C). In oligodendrocytes,
Using an antibody directed against the carboxy-terminal region of Nrg-1, we observed a
f cell (E).
ifferentiation of neural stem cells in vitro trough an interaction with
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Fig. 2. Efﬁciency of the inhibition by siRNA transfection of neural stem cells. Three days after siRNA transfection, total proteins of cultured neural stem cells were extracted and
analyzed by western blot using anti-Nrg-1, anti-ErbB2 and anti-ErbB4 antibodies. As controls, we used total protein extracts of NSC transfected with a non-target siRNA and with an
siRNA against GPHN. The intensity of the speciﬁc signal observed in these conditions was quantiﬁed by densitometry using the ImageMaster 1D Prime software (GE Healthcare°) and
was normalized by the signal obtained in each condition using an anti-actin antibody (N=3). The results were expressed as a relative percentage of expression compared to non-
transfected NSC. The signal speciﬁc to each siRNA was reduced in transfected NSC, although the actin signal remained roughly identical.
3D. Pirotte et al. / Molecular and Cellular Neuroscience xxx (2009) xxx–xxx
ARTICLE IN PRESSwestern blot experiments, D11 antibody, in cultured oligodendrocyte
protein extracts, recognized signals at 29 kDa in cytoplasm and at
140 kDa in membrane fractions. We also observed a 120 kDa isoform
in cytoplasmic extract and this last form has already been suggested
as a proprotein form (Frenzel and Falls, 2001) (Fig. 1D). In each cell
type, no signal was observed with D11 monoclonal antibody in the
nuclear fractions.
We then performed western blot analyses on the same protein
extracts using a commercial polyclonal antibody that recognized an
epitope present on the carboxyterminal region of the cytoplasmic
extremity. In the four types of cell, we observed a 55 kDa signal in both
membrane and nuclear fractions (Fig. 1E). Indeed, these signals could
result from a post-translational cleavage of the full length isoform. The
Nrg-1 intracellular domain was able to be cleaved by a γ-secretase
implicated in a Regulated Intramembrane Proteolysis process (Land-
man and Kim, 2004). This cleavage then allowed the translocation of
the intracellular domain into the nucleus. These results also suggest
that it would be possible for ICD to be cleaved and translocated into
the nucleus, as was previously demonstrated in Bao et al. (2003).
Knock-down of the expression of Nrg-1-encoded isoforms, and of ErbB2
and ErbB4 in cultured NSC
We ﬁrst validated our transfection protocol by analyzing the
percentage of dissociated NSC transfected with 6-Fam-labeled siRNA
and observed that around 50% of cells were transfected (data not
shown). Three days after various siRNA transfections, we checked, by
western blotting, the efﬁciency of siRNA against their respective
targeted protein expression and we observed a decrease in the signal
in NSC cultures for Nrg-1 (Fig. 2A), ErbB2 (Fig. 2B) and ErbB4 (Fig. 2C).
A densitometric analysis of the signal obtained by western blot shows
that the signal was decreased by at least 45% in comparison with the
control, a result which corroborates the efﬁciency of the transfection.Please cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
the Swi/Snf complex, Mol. Cell. Neurosci. (2009), doi:10.1016/j.mcn.20We then analyzed the effect of siRNA on cultured NSC proliferation
by quantifying the Ki67-positive cells (Fig. 3A). The transfection with
siRNA directed against Nrg-1-encoded isoforms, and ErbB2 and ErbB4
receptors was followed 3 days later by a statistically signiﬁcant
decrease in the number of Ki67-positive cells. There was no difference
observed between the knock-down of ErbB2 or of ErbB4 on the
number of Ki67-positive NSC. Concomitantly, the inhibition of Nrg-1
and ErbB2 led to a decrease in the proportion of Ki67-positive NSC,
which was different from a statistical point of view. Finally, the
decrease observed in response to the knock-down of ErbB4 was
statistically more important than the decrease observed with the
knock-down of Nrg-1. As the inhibition of the expression of Nrg-1,
ErbB2 and ErbB4 appeared roughly equivalent (Fig. 2), these
observations would suggest that in addition to Nrg-1-encoded
isoforms, the proliferation of NSC in culture could also be sustained
by another growth factor interacting with the ErbB4 receptor.
Five days after siRNA transfection, we quantiﬁed the numbers of
differentiated neurons, oligodendrocytes and astrocytes in the siRNA-
transfected NSC cultures. Using immunocytoﬂuorescence, neurons,
oligodendrocytes and astrocytes were respectively labeled using anti-
β III-tubulin, -O4 and -EAAT1 antibodies and were counted. The
number of neurons decreased when NSC were transfected with siRNA
directed against Nrg-1-encoded isoforms (Fig. 3B). Interestingly,
transfections using siRNA directed against ErbB2 and ErbB4 had no
effect on the number of neurons in these identical conditions (Fig. 3B).
Similar results were observed when we quantiﬁed oligodendrocyte
differentiation (Fig. 3C). Finally, the transfection of siRNA directed
against the expression of any of these genes was not followed by an
effect on the number of astrocytes differentiated from NSC in culture
(Fig. 3D). These results indicated that, endogenous Nrg-1-encoded
isoforms stimulated the differentiation of neurons and oligodendro-
cytes in cultured NSC. Moreover, the effect of Nrg-1-encoded isoforms
did not require the presence of ErbB2 and ErbB4 receptors, suggestingifferentiation of neural stem cells in vitro trough an interaction with
09.09.003
Fig. 3. Nrg-1 plays a role in the proliferation and differentiation of neural stem cells. (A) siRNA-mediated inhibition of Nrg-1, ErbB2 and ErbB4 expression induced a decrease in the
number of proliferating neural stem cells. Three days after siRNA transfection, neural stem cells were ﬁxedwith paraformaldehyde and processed for a Ki67 immunolabeling. Twenty
ﬁelds per coverslip were randomly counted, two coverslips per transfection and a total of eight transfections (N=8). In each ﬁeld, the percentage of Ki67 was calculated with regard
to the total cell number (quantiﬁed by the number of DAPI-stained nuclei). After siRNA transfection, neural stem cells were also cultivated on adherent surface, in a chemically
deﬁned medium without growth factors, to allow them to differentiate. Five days after transfection, cells were ﬁxed and processed for immunolabeling. Twenty ﬁelds per coverslip
were randomly counted, two coverslips per transfection and a total of eight transfections (N=8). (B) An immunolabeling using an anti-βIII-tubulin antibody revealed that the
number of neurons decreased only after transfection with siRNA Nrg-1 and not after transfection with siRNA erbB2 or erbB4. (C) An immunolabeling using an anti-O4 antibody
revealed that the number of oligodendrocytes decreased only after transfection with siRNA Nrg-1 but not after transfection with siRNA erbB2 or erbB4. (D) An immunolabeling using
an anti-EAAT1 antibody revealed that the number of astrocytes was not modiﬁed in any transfection. Results were expressed as a percentage of total cells quantiﬁed by DAPI-stained
nuclei, except for Graph B where results were expressed as the total number of neurons, given the fact that the quantity of transfected cells per coverslip was adapted to reduce the
amount of siRNA and transfecting reagent. Statistical analyses were performed using Student's t-test; ⁎⁎ and ⁎⁎⁎ respectively represent pb0.01 and pb0.0005.
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ARTICLE IN PRESSthat this effect was not related to an activity of the extracellular
domain of these isoforms. As we observed a cleavage of CRD-ICD in
NSC cultures, we formulated the hypothesis that this differentiation
effect is related only to ICD and its translocation into the nucleus of
NSC.
Effects of Nrg-1 type III extracellular and intracellular domain
overexpression in cultured NSC
In order to have a better understanding of the effects of ECD and
ICD, we decided to speciﬁcally overexpress ECD and ICD in cultured
NSC. Three days after transfection with plasmids containing an ECD or
ICD sequence, we performed an immunocytoﬂuorescence test using
an anti-Ki67 antibody to quantify the NSC proliferation (Fig. 4A). The
ECD overexpression did not show any signiﬁcant change in the
number of Ki67-positive NSC compared to the transfected control-
NSC. When ICD was overexpressed in NSC, we observed a decrease in
the number of Ki67-positive cells, suggesting that ICD could be
implicated in the differentiation process. Indeed, 5 days after
transfection, analysis by immunocytoﬂuorescence of the number of
neurons (βIII-tubulin-positive cells), oligodendrocytes (O4-positivePlease cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
the Swi/Snf complex, Mol. Cell. Neurosci. (2009), doi:10.1016/j.mcn.20cells) and astrocytes (EAAT1-positive cells) (Figs. 4B–D) showed that
overexpression of ICD but not of ECD was followed by an increase in
the number of neurons and oligodendrocytes in cultured NSC. No
signiﬁcant changes were observed in the number of astrocytes when
ECD or ICD were overexpressed. In order to determine whether the
increase in neurons and oligodendrocytes was a consequence of an
apoptosis rescue, we performed TUNEL labeling on ICD-transfected
NSC and observed no difference between non-transfected and
transfected NSC (data not show), indicating thus that ICD does not
play a role in the survival of neuron- or oligodendrocyte-differenti-
ating NSC.
Interactions between the intracellular domains of Nrg-1, BAF57 and Brm
So far, these results suggested that ICD was responsible for a
stimulation of neuronal or oligodendroglial differentiation in NSC
cultures. Moreover, these effects were not related to any interaction
with ErbB2 or ErbB4 receptors. As we also observed that ICD was also
present in the nuclear protein extracts of NSC, we formulated the
hypothesis that the effects of ICD could be related to a direct
interaction with another protein or other proteins. In order to identifyifferentiation of neural stem cells in vitro trough an interaction with
09.09.003
Fig. 4. Proliferation and differentiation of cultured neural stem cells are modulated by the intracellular domain of Nrg-1. The extra- and intracellular domains of the CRD-NRG form of
Nrg-1 (respectively CRD-ECD and CRD-ICD) were cloned into pcDNA3.1/V5/His-TOPO. The constructs were then transfected in cultured neural stem cells. (A) The overexpression of
Nrg-1 intracellular domain ICD (CRD-ICD) but not ECD (CRD-ECD) reduced the number of proliferating neural stem cells while increasing the number of neurons (B) and
oligodendrocytes (C). The proportion of astrocytes did not change after ECD (CRD-ECD) or ICD (CRD-ICD) overexpression (D). After transfection, cells were cultivated and processed
for various immunolabelings, as described in Fig. 5. Twenty ﬁelds per coverslip were randomly counted, two coverslips per transfection and a total of eight transfections (N=8).
Results were expressed as described in Fig. 5. Statistical analyses were performed using Student's t-test method; ⁎⁎ and ⁎⁎⁎ respectively represent pb0.01 and pb0.0005.
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ARTICLE IN PRESSthis (these) protein(s), we decided to use a yeast two-hybrid
approach (in collaboration with Hybrigenics°) and identiﬁed an
interaction of ICD with BAF57 or Smarce1, a nuclear protein of the
Swi/Snf chromatin remodeling complex (Luo and Dean, 1999; Yoo
and Crabtree, 2009). These protein complexes are able to modulate
DNA/nucleosome interactions, allowing or not transcription through
an ATPase activity of a motor protein.
In order to conﬁrm these interactions, we ﬁrst performed co-
immunoprecipitation of cultured NSC protein extract using antibodies
directed against BAF57 and Nrg-1 but also against Brg1 and Brm,
which are the ATPase subunits of the Swi/Snf chromatin remodeling
complex. In those conditions, we observed a signal corresponding to
Nrg-1 in immunoprecipitations using BAF57 and Brm antibodies but
not Brg1 antibody (Fig. 5A). Similarly, we obtained a signal for BAF57
in immunoprecipitated proteins using Nrg-1, Brg1 and Brm antibodies
(Fig. 5B). Western blot analysis using Brm antibody showed a signal
after immunoprecipitation with Nrg-1 and BAF57 antibodies (Fig. 5C).
Finally, we performed a western blot using Brg1 antibody on
immunoprecipitates obtained with Nrg-1 and BAF57, indicating an
interaction between Brg1 and BAF57 but not with Nrg-1 (Fig. 5D). In
conclusion, this co-immunoprecipitation approach revealed that in
NSC, Nrg-1 interacts with BAF57 and Brm but not with Brg1.
In order to validate these immunoprecipitation results, we also
used a Tap-tag puriﬁcation approach, in which ICD was cloned into an
expression plasmid in a frame with a dual tag (calmodulin bindingPlease cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
the Swi/Snf complex, Mol. Cell. Neurosci. (2009), doi:10.1016/j.mcn.20peptide and streptavidin binding peptide) and then expressed in
cultured NSC. Three days after transfection in NSC, proteins were
extracted and recombinant ICD was puriﬁed by a tandem afﬁnity step
in mild conditions, allowing a co-puriﬁcation of NSC proteins that
eventually interacted with ICD. We then performed western blots on
the puriﬁed proteins using antibodies directed against ICD, BAF57 and
Brm. In these three western blots, we obtained a signal corresponding
to the expected molecular weight (Fig. 5E) conﬁrming that Nrg-1
intracellular domain, BAF57 and Brm were associated in a complex in
NSC. A control Tap-tag approach (transfection of NSC with plasmid
containing tags but not the ICD sequence) did not show any Nrg-1,
BAF57 or Brm signals in those conditions.
The neuronal differentiation of neural stem cells is related to
BAF57 recruitment
Taken together, these observations suggested that ICD stimulated
the neuronal differentiation of cultured NSC by recruiting the Swi/Snf
complex via interactions with Brm and BAF57. To test such a
hypothesis, we used a lentivirus expressing an shRNA directed against
BAF57 in transduced NSC. Controls were non-infected cultured NSC
and cultured NSC infected with a non-target lentivirus. After infection,
NSCwere then transfectedwith the ICD expression plasmid. NSCwere
allowed to differentiate for 5 days in vitro and we then counted the
number of neurons (βIII-tubulin-positive cells) in each conditionifferentiation of neural stem cells in vitro trough an interaction with
09.09.003
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ARTICLE IN PRESS(Fig. 6). We were able to observe a decrease in the number of neurons
in cultured NSC transduced with a lentivirus expressing shRNA
against the expression of BAF57 and this effect was speciﬁc, as NSC
infected with a non-target lentivirus exhibited the same total number
of neurons observed in the non-infected or control condition. Forced
ICD expression in cultured NSC was followed by an increase in the
number of neurons, as already observed (Fig. 4B). This stimulation of
the number of neurons was also observed when cultured NSC were
previously infected using a non-target lentivirus. However, the
stimulation was completely inhibited when NSC were previously
transducedwith a lentivirus expressing the shRNA that inhibits BAF57Fig. 5. The intracellular domain of Nrg-1 interacted with BAF57 and Brm. Total proteins
of cultured and untransfected neural stem cells were extracted and an immunopre-
cipitation with antibodies directed against Nrg-1, BAF57, Brg1 or Brm, followed by
western blot using antibodies directed against Nrg-1 (A), BAF57 (B), Brg1 (C) or Brm
(D). As a control, we used normal rabbit IgG to immunoprecipitate total proteins of
untransfected neural stem cells. These immunoprecipitations demonstrated an
endogenous interaction in cultured neural stem cells between BAF57, Nrg-1 and Brm.
(E) Proteins extracted from NSC transfected 3 days previously with Tap-tag constructs
containing the ICD encoding sequence at either the N-terminal extremity (NTAP) or the
C-terminal extremity (CTAP) or not (control CTAP and control NTAP) were puriﬁed in a
two afﬁnity chromatography step. Eluted proteins were analyzed by western blot using
Nrg-1 ICD, BAF57 and Brm antibodies. BAF57 and Brm antibodies showed a signal in
CTAP and NTAP conditions but not in the control, indicating that these two proteins co-
puriﬁed in the two afﬁnity chromatography step with recombinant ICD.
Fig. 6. ICD induced neuronal differentiation of neural stem cells in a BAF57-dependent
manner. Dissociated neural stem cells were transduced by lentiviral particles for 1 h.
The transfection reagent with ICD-expression plasmid was then added and cells were
transferred onto coverslips after 1 h of culture in suspension. Five days after
transduction/transfection, cells were paraformaldehyde-ﬁxed and processed for an
immunolabeling using anti-βIII-tubulin antibodies. Inhibition of BAF57 expression by
shRNA induced a decrease in the number of neurons and this decrease was not
compensated by the expression of ICD. Twenty ﬁelds per coverslip were randomly
counted, two coverslips per transfection and a total of eight transfections (N=8).
Statistical analyses were performed using Student's t-test method; ⁎, ⁎⁎ and ⁎⁎⁎
respectively represent pb0.5, pb0.01 and pb0.0005.
Please cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
the Swi/Snf complex, Mol. Cell. Neurosci. (2009), doi:10.1016/j.mcn.20expression, indicating that the positive effect of ICD on the number of
neurons in these conditions depends on a BAF57 interaction.
Discussion
Type III Nrg-1 isoform, or CRD-NRG, is known to have two
transmembrane domains and to be able to undergo a proteolytic
cleavage, releasing both an extracellular domain (ECD) containing the
EGF domain known to interact with ErbB receptors and an
intracellular domain or ICD (Frenzel and Falls, 2001). It has been
demonstrated that ICD can be translocated to the nucleus of various
cell types, including neurons, and its involvement has been suggested
in a backward signaling mechanism (Bao et al., 2003). Consequently,
the main objective of this study was to characterize Nrg-1 activities in
NSC using an siRNA approach and a stimulation of expression of ECD
and ICD in neural stem cells. In these conditions, we were able to
observe that the inhibition of Nrg-1 expression was followed by a
decrease in NSC proliferation, which was less pronounced than the
siRNA-mediated inhibition of ErbB4 expression. This observation
suggested a possible role of one or more other ErbB4 ligands in the
stimulation of NSC proliferation and indicates that Nrg-1 mediates a
proliferative signal through ErbB4 receptors. However, ErbB4 inhibi-
tion has no effect on neuronal and oligodendroglial differentiation.
These observations strengthened the hypothesis of ICD backward
signaling in oligodendrocyte and neuronal differentiation. Indeed, we
found that siRNA-mediated inhibition of Nrg-1 expression in cultured
NSC was followed by a decrease in oligodendrocyte numbers, and a
stimulation of expression of ICD but not ECD was found to stimulate
oligodendrocyte differentiation. All these observations were thus
supportive of the idea that stimulation of oligodendroglial differen-
tiation is mediated by Nrg-1, as has been suggested in a previous
study (Calaora et al., 2001). However, this previous study used a
soluble and truncated form of recombinant erbB3 receptor to inhibit
the Nrg-1 signals in NSC cultures and this approach also inhibited all
ligands of the EGF family that recognize erbB3. Here, we demonstra-
ted that Nrg-1 and more precisely, ICD or the cytoplasmicifferentiation of neural stem cells in vitro trough an interaction with
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ARTICLE IN PRESScarboxyterminal extremity of the protein is responsible for this
stimulation. More interestingly, we observed that neuronal differen-
tiation was regulated by Nrg-1 and possibly by a similar ICD backward
signaling mechanism, as inhibition of Nrg-1 expression but not of
ErbB4 or ErbB2 expression was responsible for a decrease in the
number of neurons. Moreover, only the stimulation of ICD expression,
but not of ECD (part of the Nrg-1 protein isoforms which does interact
with ErbB receptors), is responsible for the stimulation of neuronal
differentiation.
The hypothesis of the backward signaling of ICD stimulating both
neuronal and the oligodendroglial differentiation was supported by
the observation that stimulated expression of ICD but not ECD in
cultured NSC was followed by an increase in the number of neurons
and oligodendrocytes from differentiated NSC. Likewise, the presence
of ICD in both membrane and nuclear protein extracts of neurons and
of oligodendrocytes was also supportive of a backward signaling of
ICD in in vitro neuronal and oligodendroglial differentiation. However,
the presence of ICD in nuclear extracts of cultured astrocytes would
suggest that ICD would act more as a permissive factor than an
inducing factor.
In this study, employing a double-hybrid approach using a mouse
E10.5-E12.5 brain cDNA library, we unraveled an interaction between
Nrg-1 and BAF57, a member of the Swi/Snf chromatin remodeling
complex. Moreover, using both co-immunoprecipitation and Tap-tag,
we conﬁrm the interaction between Nrg-1 and BAF57 and we also
demonstrated an interaction betweenNrg-1 and Brm but not between
Nrg-1 and Brg1. Brm and Brg1 are the ATPases that constitute the two
principal subunits of the Swi/Snf chromatin remodeling complex.
Although these ATPases are highly homologous, it has been
demonstrated that they are associated with different promoters
during cellular differentiation (Kadam and Emerson, 2003; Bultman
et al., 2000).
BRG1 binds to zinc ﬁnger protein through a speciﬁc domain that is
absent in Brm, and Brm interacts with ankyrin repeat proteins, which
are critical components of Notch signal transduction.
We demonstrated that ICD stimulating activity of neuronal
differentiation was mediated through a recruitment of BAF57, as the
inhibition of its expression prevented the ICD effect. This last result
implicated the Swi/Snf complex in neuronal differentiation, and it has
recently been demonstrated that a switch of the components from
this complex is related to the transition of NSC to neurons (Lessard
et al., 2007). In this context, it is possible that ICD participates in such
a switch.
In conclusion, we demonstrated that in vitro, the intracellular
domain ICD of type III Nrg-1 isoform or CRD-NRG expressed by NSC
was implicated in a backward signaling mechanism, allowing a
stimulation of neuronal and oligodendroglial differentiation. This
effect, appearing as a permissive effect, was related to an interaction
with BAF57 and possibly with Brm, both of the Swi/Snf remodeling
complex.
Experimental methods
Preparation of NSC culture
NMRI mice embryos (Harlan°, Kreuzelweg, The Netherlands) were
used as the source of neural stem cells and were euthanized by
cervical dislocation. E16 mice striata were removed and mechanically
dissociated in DEM/F12 (Invitrogen°, Brussels, Belgium) (1:1, v/v).
The cell suspension was ﬁltered through a 70 μm-pore ﬁlter, then
plated on uncoated T75 tissue culture ﬂasks (NUNC°, Langenselbold,
Germany) at 1×106 cells/20 ml in DEM/F12 supplemented with B27
(Invitrogen°) and 20 ng/ml of EGF (Sigma°, Bornem, Belgium). The
medium was supplemented with EGF every 3 days. Proliferating
spheres were collected after 5 to 7 days in culture as ﬂoating
neurospheres.Please cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
the Swi/Snf complex, Mol. Cell. Neurosci. (2009), doi:10.1016/j.mcn.20Astrocyte culture
Astrocytes were obtained from neonatal NMRI mouse cortices
that were freed of meninges, minced into small pieces of tissue with
microscissors and then suspended in MEM (Invitrogen°) supple-
mented with glucose 6 g/l and 10% FCS (Invitrogen°) and
successively ﬁltered through a 225 μm-pore and a 25 μm-pore ﬁlter.
The ﬁltered cell suspension was plated on an uncoated T25 ﬂask for
72 h. The medium was then changed and cells were grown until
conﬂuence.
Neuron culture
E16 mice hippocampi were removed and suspended into 0.25%
trypsine and 0.01% DNase (Sigma°) at 3 °C for 20 min. The enzymatic
reaction was stopped by adding 10% FCS. The hippocampi were then
washed with fresh medium and dissociated in DMEM medium
(Invitrogen°) supplemented with glucose 6 g/l, insulin 5 μg/ml
(Sigma°), 10% horse serum (Invitrogen°) and 5% FCS. The cell
suspension was plated onto Petri dishes previously coated with
0.1 mg/ml polyornithine and cultured in the same medium.
Contaminating astrocyte proliferation was inhibited by two succes-
sive cytosine arabinoside Ara-C 10−5 M (Sigma°) treatments in
DMEM medium supplemented with 5% horse serum and 10% FCS for
24 h.
Oligodendrocyte culture
E16 mice cortices were mechanically dissociated and the cell
suspension was layered on top of a pre-centrifuged (30 min at
26,000×g). Percoll density gradient (GE Healthcare°, Roosendaal,
The Netherlands 1.04 g/ml) was centrifuged for 15 min at
26,000×g. Cell debris that remained in the top aqueous phase
was discarded and the interphase below the debris and just above
the red blood cells was resuspended in PBS–HEPES. The suspension
was centrifuged three times (10 min at 400×g) in PBS–HEPES to
eliminate Percoll. The ﬁnal pellet was resuspended in DMEM
supplemented with 10 ng/ml PDGF-AA (Preprotech°, Rocky Hill,
New Jersey, USA) and 10 ng/ml biotin (Sigma°). After 3 days,
oligospheres were formed and then plated on T25 plates previously
coated with 0.1 mg/ml polyornithine in DMEM supplemented
with 0.5% FCS. Oligodendrocytes were collected after 3 days of
differentiation.
Compartmental protein extraction
Proteins were extracted from mouse E16 striata, ﬂoating spheres
and cultured neurons, astrocytes and oligodendrocytes. Neuro-
spheres were collected by centrifugation 10 min at 1000×g and
differentiated cells were collected by scrapping. Cells were harvested
in hypotonic buffer–Tris 20 mM, phosphatase inhibitors 1:20
(ActiveMotif°, Rixensart Belgium), and Complete protease inhibitor
cocktail (Roche°, Brussels, Belgium). Extractions were fractioned into
soluble proteins (fraction I) and non-soluble proteins (fraction II) by
centrifugation at 400×g for 10 min at 4 °C. Fraction II (which
contained nuclear proteins) was resuspended in lysis buffer (Active
Motif°) and incubated for 30 min at 4 °C under gentle agitation, then
centrifuged at 14,000×g for 10 min. This step allowed the recovery
of nuclear proteins in the supernatant (fraction III). Fraction I was
then centrifuged at 125,000×g for 30 min at 4 °C. The supernatant
(fraction IV) contained soluble cytoplasmic proteins and the pellet
(fraction V) contained membrane proteins. Fraction V was resus-
pended in MBS buffer (MES 25 mM, NaCl 50 mM, 1% Triton X-100).
Protein concentrations were quantiﬁed by the RC/DC Protein Assay
(Bio-Rad°, Nazareth, Belgium) based on the classical method of
Lowry.ifferentiation of neural stem cells in vitro trough an interaction with
09.09.003
Table 2
Sequences of the sense and antisense oligonucleotides used as siRNA after annealing.
Sense Antisense
siRNA Nrg-1 CCAAGUAAUGUCCAAUAAU AUUAUUGGACAUUACUUGG
siRNA ErbB2 GGGAGGAGUUUUGAUCCGU ACGGAUCAAAACUCCUCCC
siRNA ErbB4 CCUGACCGAAAUACUAAAU AUUUAGUAUUUCGGUCAGG
siRNA GPHN GCCCUUAGUCUUUAAGACG CGUCUUAAAGACUAAGGGC
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Equivalent amounts of extracted proteins were loaded on each
lane of a 10% polyacrylamide gel (Nupage, Invitrogen°). After
electrophoresis, proteins were transferred onto PVDF membrane
(Roche°). After blocking in 0.2% puriﬁed casein (Tropix°, Bedford,
MA, USA), the membrane was incubated with primary antibody
overnight at 4 °C and then with a secondary antibody conjugated
with peroxidase for 1 h at room temperature. Immunoreactive
signals were visualized by enhanced chemiluminescence (Super-
Signal WestPico, Pierce°, Brussels, Belgium). Primary antibodies used
were: D11 monoclonal antibody (home made, see Supplementary
data); Nrg-1/ICD (Upstate°, Dundee, UK; 1:1000); actin (AbCam°,
Cambridge, UK; 1:200); ErbB2 (Santa Cruz°, California, USA; 1/200);
ErbB4 (Santa Cruz°; 1/200); BAF57 (Sigma°; 1:1000); Brg1 (Abcam°;
1/1000) and Brm (Abcam°; 1/750). Secondary antibodies conjugated
with peroxidase were RG-16 mouse monoclonal anti-rabbit
(AbCam°) used at 1:3000, and goat anti-mouse (Sigma°) used at
1:2000.
Transfection with plasmid constructs
The extra- and intracellular domains of CRD-NRG (respectively
ECD and ICD) were ampliﬁed by PCR (primer sequences displayed in
Table 1) – using as a template the previously CRD-NRG cloned cDNA
(Bermingham-McDonogh et al., 1997) – and were inserted into
pcDNA3.1/V5/His-TOPO (Invitrogen°). Plasmid constructions were
sequenced. For the purpose of transfection, neurospheres were
mechanically dissociated and individualized NSC were then trans-
fected in suspension using Fugene° HD (Roche°) according to the
manufacturer's instructions. Cells were then plated on laminin-coated
coverslips (0.01 mg/ml) for 48–96 h.
Transfection with siRNA
Before transfection, neurospheres were mechanically dissociated
and ﬁltered through a 10 μm-pore ﬁlter. The ﬁltered cell suspension
was transfected with 200 nM of siRNA (sequences displayed in Table
2) (Ambion°, Lennik, Belgium). Transfections were performed using
Neofectine° (Ambion°) according to the manufacturer's instructions.
Transfected cells were then plated on laminin-coated (0.01 mg/ml)
coverslips for 72–120 h.
Immunocytoﬂuorescence
Cells were ﬁxed with 4% paraformaldehyde for 20 min at room
temperature, and were then permeabilized and blocked (unspeciﬁc
binding sites) by a 30 min incubation at room temperature in
blocking solution (10% donkey serum and 0.3% Triton X-100 in
1×PBS). Cells were then incubated for 1 h at RT with primary
antibodies diluted in a 10% donkey serum and 0.1% Triton X-100 in
PBS. We used antibodies directed against Ki67 (BD Biosciences°,
Erembodegem, Belgium; 1:250), EAAT1 (AbCam°; 1:250), βIII-
tubulin (Millipore°, Brussels, Belgium; 1:1000), and O4 (Millipore°,
1:100). Cells were washed and incubated with secondary antibodies:
FITC conjugated donkey anti-mouse (Jackson ImmunoResearch°,
West Grove, USA; 1:500) or rhodamine conjugated donkey anti-
rabbit (Jackson ImmunoResearch°, 1:500). Immunostained cover-Table 1
Sequences of primers used for ampliﬁcation of CRD-ECD and CRD-ICD sequences.
CRD-ECD for 5′ CACCATGGAGATTTATTCCCCAG 3′
CRD-ECD rev 5′ GATGCCAGTAATTGTCACGCAAC 3′
CRD-ICD for 5′ CACCCAATTACTGGCATCTGTATC3′
CRD-ICD rev 5′ TACAGCAATAGGGTCTTGGTTAG 3′
Please cite this article as: Pirotte, D., et al., Neuregulin-1 modulates the d
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microscope equipped with a krypton/argon gas layer (Olympus®
Fluoview 1000, Aartselaar, Belgium). Positive cells were counted
within 20 randomly selected microscope ﬁelds per coverslip.
Immunoprecipitation
Cells were harvested in lysis buffer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 3 mM EDTA and 1% Triton X-100), supplemented with
phosphatase inhibitors (Roche°) and protease inhibitors (Complete,
Roche°). Lysates were clariﬁed by centrifugation at 16,000×g for
20 min at 4 °C. Supernatants were precleared with Protein G–agarose
(Roche°) for 1 h and then incubated with 2 μg of normal rabbit IgG as a
negative control (Santa Cruz°), Nrg-1I/CD (Upstate°), BAF57 (Sigma°),
Brg1 (Abcam°) or Brm (Abcam) for 2 h at 4 °C. Protein G–agarose was
then added for an overnight incubation at 4 °C. After centrifugation,
immunoprecipitates were washed 3 times in lysis buffer and were
subjected to western blot analysis after elution in electrophoresis
loading buffer.
Tap-tag puriﬁcation
The intracellular domain (ICD) of Nrg-1 was ampliﬁed by PCR
(sequences displayed in Table 3) using as a template the previously
CRD-NRG cloned cDNA, and it was then cloned into pCTAP and pNTAP
expression vectors (Stratagene°, La Jolla, United States). Both vectors
contained two Tap-tags, a streptavidin binding peptide (SBP) and a
calmodulin binding peptide (CBP), resulting in the fusion of the Tap-
tags to the C-terminus (pCTAP) or N-terminus (pNTAP) of the
intracellular domain. Plasmids were prepared using Sigma MidiPrep
Kits (Sigma°), checked by sequencing. Dissociated NSC were trans-
fected with these plasmids by electroporation (BTX° ECM 830
apparatus, 1 pull, 100 V, 10 ms). Transfected cells were plated on
uncoated T75 tissue culture ﬂasks at 2×106 cells/20 ml (NUNC°,
Langenselbold, Germany) in DEM/F12 (Invitrogen°) supplemented
with B27 (Invitrogen°) for 3 days. Cells were then collected and
resuspended in lysis buffer provided with the InterPlay TAP
Puriﬁcation Kit (Stratagene°).
Lentiviral transduction
Dissociated and ﬁltered neurospheres were transduced by addi-
tion of 100 μl lentivirus expressing shRNA directed against BAF57
(Sigma°) for 1 h at 37 °C. The cell suspension was mixed every 15 min
to avoid the formation of aggregates. A proportion of the cells was also
transfected with plasmid containing the ICD sequence, as explained
previously. Transduced cells were plated onto laminin-coated
(0.01 mg/ml) coverslips. We used non-target lentivirus (Sigma°) as
a negative control and lentivirus turboGFP as a positive control
(Sigma°).Table 3
Sequences of the primers used for PCR ampliﬁcation of CRD-ICD before cloning into
pNTAP or pCTAP.
Tap-tag NRG-ICD for 5′ AGCGATATCTGCTGACAATTACTGGCATCTG 3′
Tap-tag NRG-ICD rev 5′ AGCCTCGAGTACAGCAATAGGGTCTTGGTTAG 3′
ifferentiation of neural stem cells in vitro trough an interaction with
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